Previous Close | 0.1000 |
Open | 0.0300 |
Bid | 0.0000 |
Ask | 0.4200 |
Strike | 230.00 |
Expire Date | 2025-03-21 |
Day's Range | 0.0300 - 0.1000 |
Contract Range | N/A |
Volume | |
Open Interest | 5 |
Johnson & Johnson (JNJ) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Johnson & Johnson's (NYSE:JNJ) stock up by 8.5% over the past three months. We wonder if and what role the company's...
JNJ's Innovative Medicines unit sales are expected to have been driven by drugs like Darzalex and Stelara. It remains to be seen if MedTech sales improved.